# Phase I/II Randomized Clinical Trial of Allogeneic Adipose Tissue-derived Mesenchymal Stromal Cells Systemic Infusion in Severe Systemic Sclerosis

> **NCT06722105** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 18 (estimated)

## Conditions studied

- Severe Systemic Sclerosis

## Interventions

- **BIOLOGICAL:** 2 infusions of MSC
- **BIOLOGICAL:** 1 infusion of MSC
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06722105
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2026-04-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06722105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06722105, "Phase I/II Randomized Clinical Trial of Allogeneic Adipose Tissue-derived Mesenchymal Stromal Cells Systemic Infusion in Severe Systemic Sclerosis". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06722105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*